Cargando…
Using a 31-Gene Expression Profile Test to Stratify Patients with Stage I–II Cutaneous Melanoma According to Recurrence Risk: Update to a Prospective, Multicenter Study
SIMPLE SUMMARY: Many people with skin cancer will have their cancer come back. The 31-gene expression profile (31-GEP) test can help predict if a cancer has a low (Class 1) or high (Class 2) chance of returning. This study looked at 86 patients with early skin cancer to see how well the 31-GEP test...
Autores principales: | Podlipnik, Sebastian, Boada, Aram, López-Estebaranz, Jose L., Martín-González, Manuel M., Redondo, Pedro, Martin, Brian, Quick, Ann P., Bailey, Christine N., Kurley, Sarah J., Cook, Robert W., Puig, Susana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8870692/ https://www.ncbi.nlm.nih.gov/pubmed/35205808 http://dx.doi.org/10.3390/cancers14041060 |
Ejemplares similares
-
Early outcome of a 31‐gene expression profile test in 86 AJCC stage IB‐II melanoma patients. A prospective multicentre cohort study
por: Podlipnik, S., et al.
Publicado: (2019) -
Topographical and Chronological Analysis of Thin Cutaneous Melanoma’s Progressions: A Multicentric Study
por: Chousakos, Emmanouil, et al.
Publicado: (2023) -
Long-Term Outcomes in a Multicenter, Prospective Cohort Evaluating the Prognostic 31-Gene Expression Profile for Cutaneous Melanoma
por: Hsueh, Eddy C., et al.
Publicado: (2021) -
31-Gene Expression Profile Testing in Cutaneous Melanoma and Survival Outcomes in a Population-Based Analysis: A SEER Collaboration
por: Bailey, Christine N., et al.
Publicado: (2023) -
Initial Stage of Cutaneous Primary Melanoma Plays a Key Role in the Pattern and Timing of Disease Recurrence
por: ERTEKIN, Sümeyre Seda, et al.
Publicado: (2021)